Cigna Launches New Military Service Grant
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: Newsfilter
- New Grant Launch: The Cigna Group Foundation has announced the launch of the 'Courage in Service' grant, committing $1.5 million over the next 10 years to support the health and well-being of military and veteran communities by prioritizing social connections.
- Annual Funding Program: Each year, $150,000 will be awarded to a nonprofit organization serving military and veteran communities to support programs that strengthen connections, improve well-being, and increase stability for families navigating key life transitions.
- Leadership Tribute: This grant honors David M. Cordani's 17 years as CEO of The Cigna Group, who has focused on improving the health of military and veteran communities, ensuring that the legacy of respect and support for service members continues.
- Application Now Open: The grant is now open for eligible nonprofit organizations to apply, with a deadline of July 30, 2026, and funding expected to begin on January 1, 2027, further enhancing community health and support services.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CI
Wall Street analysts forecast CI stock price to rise
16 Analyst Rating
14 Buy
2 Hold
0 Sell
Strong Buy
Current: 279.460
Low
300.00
Averages
335.63
High
378.00
Current: 279.460
Low
300.00
Averages
335.63
High
378.00
About CI
The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cigna Launches New Military Service Grant
- New Grant Launch: The Cigna Group Foundation has announced the launch of the 'Courage in Service' grant, committing $1.5 million over the next 10 years to support the health and well-being of military and veteran communities by prioritizing social connections.
- Annual Funding Program: Each year, $150,000 will be awarded to a nonprofit organization serving military and veteran communities to support programs that strengthen connections, improve well-being, and increase stability for families navigating key life transitions.
- Leadership Tribute: This grant honors David M. Cordani's 17 years as CEO of The Cigna Group, who has focused on improving the health of military and veteran communities, ensuring that the legacy of respect and support for service members continues.
- Application Now Open: The grant is now open for eligible nonprofit organizations to apply, with a deadline of July 30, 2026, and funding expected to begin on January 1, 2027, further enhancing community health and support services.
See More
Cigna Launches New Military Service Grant
- New Grant Launch: The Cigna Group Foundation has announced the launch of the $1.5 million 'Courage in Service' grant, aimed at supporting the health and well-being of military and veteran communities, reflecting the company's long-standing commitment to this demographic.
- Annual Funding Program: Each year, $150,000 will be awarded to a nonprofit organization to support programs that strengthen social connections, improve well-being, and increase stability for military families navigating key life transitions.
- CEO Retirement and Legacy: The grant's introduction coincides with David Cordani's retirement as CEO of The Cigna Group, transitioning to executive chair of the board, marking a continuation of his 17-year focus on supporting military communities.
- Application Open and Timeline: Grant applications are now open until July 30, 2026, with funding expected to commence on January 1, 2027, further enhancing support for military and veteran communities.
See More
Cigna Group Foundation Funds Youth Mental Health Initiatives
- Funding Announcement: The Cigna Group Foundation has announced $3 million in grants to 22 nonprofits aimed at improving youth mental health services across 10 states, reflecting the company's commitment to social responsibility and proactive engagement with mental health issues.
- Program Expansion: This funding is part of the Foundation's three-year, $9 million commitment, with 40% of grantees continuing or expanding previously funded programs, indicating the significance and sustained impact of these initiatives within communities.
- Early Intervention Focus: The funded programs emphasize expanding access to mental health services for youth aged 5-18 and equipping parents and educators, aiming to strengthen pathways for early intervention and care, thereby enhancing the overall mental health landscape for young people.
- Partnership Development: Cigna's collaboration with Boys & Girls Clubs of America has expanded mental health support nationwide, with 90% of clubs completing trauma-informed training since the partnership began in 2024, showcasing the company's proactive efforts in promoting mental health education.
See More
VFLO Stock Price Analysis and ETF Dynamics
- Price Fluctuation Analysis: VFLO's 52-week low is $34.11 and high is $48.24, with the current trading price at $45.17, indicating stock price volatility near its high, which may influence investor buying decisions.
- Technical Analysis Tool: Comparing the current stock price to the 200-day moving average can provide valuable insights for investors, helping to assess market trends and potential buying opportunities.
- ETF Trading Mechanism: ETFs trade similarly to stocks, where investors are buying and selling 'units' that can be created or destroyed based on demand, impacting the liquidity and market performance of the ETF.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in ETF shares outstanding focuses on significant inflows or outflows, which can affect the underlying stocks held by the ETF and subsequently influence overall market dynamics.
See More
Employers Plan to Cut GLP-1 Drug Coverage
- Employer Coverage Changes: According to the Business Group on Health, about 10% of employers plan to drop coverage for GLP-1 weight-loss drugs by 2027, despite 67% of large employers still covering them in 2026, which could lead to increased healthcare costs for employees.
- Rising Drug Demand: The introduction of oral options has significantly increased demand for GLP-1 drugs, particularly Wegovy and Foundayo, which can reduce weight by 11% and 14% respectively, attracting more patients who have never tried these medications, thereby raising employer costs.
- Insurance Policy Adjustments: Cigna ceased coverage for weight-loss medications for its employees in July, prompting them to seek discounted prices directly from drug manufacturers' websites, a shift that may influence future drug coverage policies.
- Market Cost Pressure: Despite a decrease in drug prices, the growing patient population continues to exert significant cost pressure on employers, with industry experts anticipating further reductions in GLP-1 coverage next year.
See More
Cigna: A Stable Cash-Generating Stock Amid Market Volatility
- Steady Earnings Growth: Cigna reported an adjusted EPS of $7.79 in Q1 and raised its full-year guidance to at least $30.35, marking the fifth consecutive quarter of EPS beats, which, while modest, reflects the company's consistent profitability.
- Supportive Buyback Program: With approximately $2.5 billion remaining on its $6 billion repurchase program, Cigna not only enhances shareholder returns but also supports its stock price, boosting market confidence in its stability.
- Attractive Valuation: Trading just above $290, Cigna's forward P/E ratio stands at about 9.5x, significantly lower than the S&P's current multiples, while offering a dividend yield of 2.2%, providing investors with a compelling income opportunity.
- Flexible Options Strategy: By selling the $280 cash-secured put, investors can earn around 2% in about six weeks; if assigned below $280, their effective cost basis drops to approximately $274, enhancing the investment's margin of safety.
See More
Cigna Launches New Military Service Grant
- New Grant Launch: The Cigna Group Foundation has announced the launch of the 'Courage in Service' grant, committing $1.5 million over the next 10 years to support the health and well-being of military and veteran communities by prioritizing social connections.
- Annual Funding Program: Each year, $150,000 will be awarded to a nonprofit organization serving military and veteran communities to support programs that strengthen connections, improve well-being, and increase stability for families navigating key life transitions.
- Leadership Tribute: This grant honors David M. Cordani's 17 years as CEO of The Cigna Group, who has focused on improving the health of military and veteran communities, ensuring that the legacy of respect and support for service members continues.
- Application Now Open: The grant is now open for eligible nonprofit organizations to apply, with a deadline of July 30, 2026, and funding expected to begin on January 1, 2027, further enhancing community health and support services.
See More
Cigna Launches New Military Service Grant
- New Grant Launch: The Cigna Group Foundation has announced the launch of the $1.5 million 'Courage in Service' grant, aimed at supporting the health and well-being of military and veteran communities, reflecting the company's long-standing commitment to this demographic.
- Annual Funding Program: Each year, $150,000 will be awarded to a nonprofit organization to support programs that strengthen social connections, improve well-being, and increase stability for military families navigating key life transitions.
- CEO Retirement and Legacy: The grant's introduction coincides with David Cordani's retirement as CEO of The Cigna Group, transitioning to executive chair of the board, marking a continuation of his 17-year focus on supporting military communities.
- Application Open and Timeline: Grant applications are now open until July 30, 2026, with funding expected to commence on January 1, 2027, further enhancing support for military and veteran communities.
See More
Cigna Group Foundation Funds Youth Mental Health Initiatives
- Funding Announcement: The Cigna Group Foundation has announced $3 million in grants to 22 nonprofits aimed at improving youth mental health services across 10 states, reflecting the company's commitment to social responsibility and proactive engagement with mental health issues.
- Program Expansion: This funding is part of the Foundation's three-year, $9 million commitment, with 40% of grantees continuing or expanding previously funded programs, indicating the significance and sustained impact of these initiatives within communities.
- Early Intervention Focus: The funded programs emphasize expanding access to mental health services for youth aged 5-18 and equipping parents and educators, aiming to strengthen pathways for early intervention and care, thereby enhancing the overall mental health landscape for young people.
- Partnership Development: Cigna's collaboration with Boys & Girls Clubs of America has expanded mental health support nationwide, with 90% of clubs completing trauma-informed training since the partnership began in 2024, showcasing the company's proactive efforts in promoting mental health education.
See More
VFLO Stock Price Analysis and ETF Dynamics
- Price Fluctuation Analysis: VFLO's 52-week low is $34.11 and high is $48.24, with the current trading price at $45.17, indicating stock price volatility near its high, which may influence investor buying decisions.
- Technical Analysis Tool: Comparing the current stock price to the 200-day moving average can provide valuable insights for investors, helping to assess market trends and potential buying opportunities.
- ETF Trading Mechanism: ETFs trade similarly to stocks, where investors are buying and selling 'units' that can be created or destroyed based on demand, impacting the liquidity and market performance of the ETF.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in ETF shares outstanding focuses on significant inflows or outflows, which can affect the underlying stocks held by the ETF and subsequently influence overall market dynamics.
See More
Employers Plan to Cut GLP-1 Drug Coverage
- Employer Coverage Changes: According to the Business Group on Health, about 10% of employers plan to drop coverage for GLP-1 weight-loss drugs by 2027, despite 67% of large employers still covering them in 2026, which could lead to increased healthcare costs for employees.
- Rising Drug Demand: The introduction of oral options has significantly increased demand for GLP-1 drugs, particularly Wegovy and Foundayo, which can reduce weight by 11% and 14% respectively, attracting more patients who have never tried these medications, thereby raising employer costs.
- Insurance Policy Adjustments: Cigna ceased coverage for weight-loss medications for its employees in July, prompting them to seek discounted prices directly from drug manufacturers' websites, a shift that may influence future drug coverage policies.
- Market Cost Pressure: Despite a decrease in drug prices, the growing patient population continues to exert significant cost pressure on employers, with industry experts anticipating further reductions in GLP-1 coverage next year.
See More
Cigna: A Stable Cash-Generating Stock Amid Market Volatility
- Steady Earnings Growth: Cigna reported an adjusted EPS of $7.79 in Q1 and raised its full-year guidance to at least $30.35, marking the fifth consecutive quarter of EPS beats, which, while modest, reflects the company's consistent profitability.
- Supportive Buyback Program: With approximately $2.5 billion remaining on its $6 billion repurchase program, Cigna not only enhances shareholder returns but also supports its stock price, boosting market confidence in its stability.
- Attractive Valuation: Trading just above $290, Cigna's forward P/E ratio stands at about 9.5x, significantly lower than the S&P's current multiples, while offering a dividend yield of 2.2%, providing investors with a compelling income opportunity.
- Flexible Options Strategy: By selling the $280 cash-secured put, investors can earn around 2% in about six weeks; if assigned below $280, their effective cost basis drops to approximately $274, enhancing the investment's margin of safety.
See More
